Thiazolidinediones (glitazones) may increase the risk of fracture in women

From the excellent blog “Prescribing Advice for GPs“: “The Journal of the Canadian Medical Association (CMAJ) has published the results of a systematic review and meta-analysis that aimed to quantify the fracture risk associated with glitazone therapy. There is also an accompanying editorial. This study has also reached the general media (BBC). The analysis examined data […]

NPS RADAR: Rosiglitazone is a third-line choice in diabetes type 2 treatment

Summary of the review of the NPS RADAR on rosiglitazone (Avandia) Rosiglitazone improves glycaemic control but there is a lack of evidence that it improves diabetes–related clinical complications and mortality. Prescribers should consider this —along with recently emerging safety information — when assessing the ratio of potential harms and benefits for each patient. Rosiglitazone is […]

Are you a visual learner interested in learning psychopharmacology? Click here to get our videos